FDA Inspection 1267093 - Glenmark Pharmaceuticals Inc USA - June 17, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Glenmark Pharmaceuticals Inc USA

Record Details

This FDA Inspection record concerns Glenmark Pharmaceuticals Inc USA, with an inspection on June 17, 2025, issued by the Atlanta District Office, covering human drugs.

Company: Glenmark Pharmaceuticals Inc USA
Inspection Date: June 17, 2025
Product Type: Human Drugs
Office: Atlanta District Office

Open in Dashboard

ID · 3ab7d010-f073-47f9-8788-ab4b11e320be

Violation Codes5

21 CFR 211.113(b)21 CFR 211.22(a)21 CFR 211.25(a)21 CFR 211.67(b)21 CFR 211.84(d)(2)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Glenmark Pharmaceuticals Inc USAJune 17, 2025